Drug Interaction in Infectious Diseases


The medical hurt which may be majorly prevented is drug interactions within the infectious diseases. Drug interactions represent a serious risk to patients. The approved drug product labels for anti-infective medication, direct-acting antivirals for HCV, HIV medication unveil that drug interactions gift an enormous challenge for patients and their attention suppliers. Non-CYP enzymes, CYP enzymes, and changes in stomachic pH, the ever-growing list of drug transporters could also be the reason behind interactions. There are alternative concerns that incorporate interactions thanks to food parts, flavouring medications and biological merchandise.



 


  • Fluoxetine and Phenelzine
  • Digoxin and Quinidine
  • Warfarin and Diflunisal
  • Theophylline and Ciprofloxacin

Related Conference of Drug Interaction in Infectious Diseases

August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic
December 15-16, 2025

7th Global Experts Meeting on Infectious Diseases

Barcelona, Spain
December 17-18, 2025

17th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands

Drug Interaction in Infectious Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in